Daniel Serin
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
-
- Breast Cancer Treatment Studies 15
- Oncology 21
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 7
- Lymphatic System and Diseases 3
- Global Cancer Incidence and Screening 3
- Co-authors
- Pierre Kerbrat (8 shared papers)Mario Campone (6 shared papers)T. Delozier (3 shared papers)P. Fumoleau (4 shared papers)M. Spielmann (4 shared papers)Henri Hubert Roche (5 shared papers)Alain Monnier (4 shared papers)Alain H. Lortholary (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)The Lancet (2 papers)European Journal of Cancer (2 papers)The Oncologist (2 papers)
- Partner nations
- FranceUnited StatesMonaco
In The Last Decade
Daniel Serin
40 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 912
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 265
- Pathology and Forensic Medicine 150
- Pulmonary and Respiratory Medicine 221
Countries citing papers authored by Daniel Serin
This map shows the geographic impact of Daniel Serin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Serin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Serin more than expected).
Fields of papers citing papers by Daniel Serin
This network shows the impact of papers produced by Daniel Serin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Serin. The network helps show where Daniel Serin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Serin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 461 | |
| 2 | 2013 | 264 | |
| 3 | 2009 | 249 | |
| 4 | 2011 | 247 | |
| 5 | 2007 | 112 | |
| 6 | 2019 | 104 | |
| 7 | 2010 | 98 | |
| 8 | 2003 | 85 | |
| 9 | 2006 | 74 | |
| 10 | 2007 | 73 | |
| 11 | 2006 | 59 | |
| 12 | 2016 | 32 | |
| 13 | 2012 | 30 | |
| 14 | 2006 | 23 | |
| 15 | 2008 | 23 | |
| 16 | 2011 | 20 | |
| 17 | 2007 | 19 | |
| 18 | 2007 | 18 | |
| 19 | 1998 | 14 | |
| 20 | 2007 | 13 |
About Daniel Serin
Daniel Serin is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Physiology, having authored 47 papers that have together received 2.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (7 papers), Lymphatic System and Diseases (3 papers), Family Support in Illness (3 papers), Global Cancer Incidence and Screening (3 papers), BRCA gene mutations in cancer (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Cancer Research (912 citations), Oncology (1.2k citations), Radiology, Nuclear Medicine and Imaging (265 citations), Pathology and Forensic Medicine (150 citations) and Pulmonary and Respiratory Medicine (221 citations). Daniel Serin has collaborated with scholars based in France, United States and Monaco. Frequent co-authors include Pierre Kerbrat, Mario Campone, T. Delozier, P. Fumoleau, M. Spielmann, Henri Hubert Roche, Alain Monnier, Alain H. Lortholary, Andrew Kramar and Gilles Romieu. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, The Lancet, European Journal of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.